IndraLab

Statements


EGF inhibits COPS6. 1 / 1
| 1

reach
"Congruently, PD98059 increased the turnover rate of CSN6 in the presence of the de novo protein synthesis inhibitor cycloheximide (XREF_FIG), whereas EGF, which induced ERK activation, reduced CSN6 turnover (XREF_FIG)."